XML 81 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurements - Narrative (Details)
3 Months Ended 12 Months Ended
May 19, 2021
USD ($)
milestone
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Jan. 04, 2021
USD ($)
milestone
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Fair value of contingent consideration upon acquisition   $ 0 $ 1,142,000      
Equity method investments   18,400,000   $ 20,500,000    
Impairment of non-marketable investments   0 0      
Equity investments included in other assets   12,600,000   12,600,000    
Unrealized gain, before tax     6,900,000      
Impairment of long-lived assets held-for-use   0 0      
Impairment Loss, Before Tax   9,600,000        
Impairment of non-financial assets   0 $ 0      
Fair Value, Measurements, Recurring | Level 1            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Investments for deferred compensation plan   29,884,000   28,213,000    
Small Technology Acquisition            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Future potential earn-out payments $ 10,000,000          
Number of technical development milestones | milestone 3          
Fair value of contingent consideration upon acquisition $ 10,000,000          
Small Technology Acquisition | First Technical Development Milestone            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Payment of contingent consideration for business acquisition         $ 900,000  
Small Technology Acquisition | Second Technical Development Milestone            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Payment of contingent consideration for business acquisition       4,000,000    
Second Small Technology Acquisition            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Future potential earn-out payments           $ 3,000,000
Number of technical development milestones | milestone           2
Second Small Technology Acquisition | First Technical Development Milestone            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Payment of contingent consideration for business acquisition       $ 2,000,000    
Second Small Technology Acquisition | Second Technical Development Milestone            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Contingent consideration   $ 1,000,000